Succession Agreement Sample Contracts

Share Cite Term
Link

Embed (HTML)
Mylan B.V. – Transition and Succession Agreement (May 10th, 2017)

THIS TRANSITION AND SUCCESSION AGREEMENT (this "Agreement") is entered into effective as of the 24th day of March, 2017, by and between Mylan Inc., a Pennsylvania corporation (the "Company"), and Daniel M. Gallagher (the "Executive").

Mylan B.V. – Transition and Succession Agreement (August 9th, 2016)

THIS TRANSITION AND SUCCESSION AGREEMENT (this "Agreement") is entered into effective as of the 6th day of June, 2016, by and between Mylan Inc., a Pennsylvania corporation (the "Company"), and Kenneth S. Parks (the "Executive").

Succession Agreement (January 5th, 2016)

This SUCCESSION AGREEMENT (this "Agreement") is made and entered into as of the 3rd day of January, 2016 (the "Effective Date"), by and between The Brink's Company, a Virginia corporation (the "Company"), and Thomas C. Schievelbein (the "Executive" and, together with the Company, the "Parties" and each, a "Party").

Succession Agreement (November 4th, 2015)

This SUCCESSION AGREEMENT (the "Agreement") is made and entered into as of the 17th day of August 2015 (the "Effective Date"), by and between Cimarex Energy Co., a Delaware corporation (the "Company"), and Paul Korus ("Executive").

Mylan B.V. – Transition and Succession Agreement Waiver Letter (October 30th, 2015)

Reference is made to your Transition and Succession Agreement with Mylan Inc., as such agreement has been and may be amended from time to time (the "T&S Agreement"). The T&S Agreement provides for the possibility of enhanced benefits or rights following a Change in Control (as such term is defined in the T&S Agreement) of Mylan N.V. (the "Company"). By executing this waiver letter, for good and valuable consideration (including your continued employment and continued participation in the incentive plans and programs of the Company and its subsidiaries), you acknowledge and agree that the Company's proposed acquisition of Perrigo Company plc shall not constitute a Change in Control for any purpose of the T&S Agreement. All other provisions of the T&S Agreement, as modified by the foregoing, shall remain in full force and effect notwithstanding this waiver letter.

Transition and Succession Agreement Waiver Letter (March 2nd, 2015)

Reference is made to your Transition and Succession Agreement with Mylan Inc. (the "Company"), as such agreement has been and may be amended from time to time (the "T&S Agreement"). The T&S Agreement provides for the possibility of enhanced benefits or rights following a Change in Control of the Company (as such term is defined in the T&S Agreement). By executing this waiver letter, for good and valuable consideration (including your continued employment and continued participation in the Company's incentive plans and programs), you acknowledge and agree that the transactions consummated pursuant to the Business Transfer Agreement and Plan of Merger, dated as of July 13, 2014, by and among Abbott Laboratories, an Illinois corporation, the Company and the other parties thereto, as such agreement may be amended from time to time, shall not constitute a Change in Control for any purpose of the T&S Agreement. All other provisions of the T&S Agreement, as modified by the foregoing, shall

Danielson Holding Corporation – Re: Succession Agreement (January 5th, 2015)

This Succession Agreement (the Agreement) will confirm our mutual understanding and agreements regarding your assistance in finding your successor and facilitating a successful transition to a new President and Chief Executive Officer of Covanta Holding Corporation (Parent) and its subsidiaries, including without limitation Covanta Energy LLC (Covanta Energy and collectively, the Covanta Companies). Unless otherwise defined herein, capitalized terms shall have the meaning ascribed to them in the Severance Plan for Covanta Energy Corporation Senior Officers adopted on February 24, 2010, as amended (the Severance Plan).

Succession Agreement (January 31st, 2013)

This SUCCESSION AGREEMENT (the Agreement) is made and entered into as of the 30th day of January, 2013 (the Effective Date), by and between Bill Barrett Corporation, a Delaware corporation (the Company), and Kurt M. Reinecke (the Executive).

Succession Agreement (January 9th, 2013)

This SUCCESSION AGREEMENT (the Agreement) is made and entered into as of the 9th day of January, 2013 (the Effective Date), by and between Bill Barrett Corporation, a Delaware corporation (the Company), and Fredrick J. Barrett (the Executive).

Succession Agreement (January 20th, 2012)

This SUCCESSION AGREEMENT (the "Agreement") is made and entered into as of the 19th day of January, 2012, by and among James V. O'Donnell (the "Executive") and American Eagle Outfitters, Inc., a Delaware corporation (the "Company"). All capitalized terms used, but not defined, herein shall have the meanings ascribed to them in the amended and restated Employment Agreement between the Executive and the Company, dated as of January 11, 2010 (the "Employment Agreement").

Succession Agreement (November 14th, 2011)

This SUCCESSION AGREEMENT (the "Agreement") is made and entered into as of the 13th day of November, 2011 (the "Effective Date"), by and among Michael T. Dan (the "Executive") and The Brink's Company, a Virginia corporation (the "Company").

Succession Agreement (October 19th, 2011)

This SUCCESSION AGREEMENT (the "Agreement") is made and entered into as of the 18th day of October, 2011, by and among Michael W. Laphen (the "Executive") and Computer Sciences Corporation, a Nevada corporation (the "Company"). All capitalized terms used, but not defined, herein shall have the meanings ascribed to them in the Amended and Restated Management Agreement between the Executive and the Company, dated as of December 20, 2010 (the "Management Agreement").

Succession Agreement (July 6th, 2011)

This Succession Agreement (this Agreement) is made as of July 1, 2011, between Kyle R. Kirkland and Steinway Musical Instruments, Inc., a Delaware corporation (SMI).

Transition and Succession Agreement (April 30th, 2010)

THIS TRANSITION AND SUCCESSION AGREEMENT (this Agreement) is entered into effective as of the 1st day of April, 2010 (this Agreement), by and between Mylan Inc., a Pennsylvania corporation (the Company), and John Sheehan (the Executive).

Ulta Salon Cosmetics & Fragrance – Succession Agreement (April 27th, 2010)

THIS SUCCESSION AGREEMENT (the Agreement) is entered into April 23, 2010, by and between Ulta Salon, Cosmetics & Fragrance, Inc., a Delaware corporation (the Company), and Lyn Kirby (the Executive).

Amendment No. 1 to Transition and Succession Agreement (February 26th, 2010)

THIS AMENDMENT TO THE TRANSITION AND SUCCESSION AGREEMENT (this Amendment) by and between Mylan Inc. (the Company) and Daniel C. Rizzo, Jr. (the Executive), is made as of December 22, 2008.

Amendment No. 2 to Transition and Succession Agreement (February 26th, 2010)

THIS AMENDMENT NO. 2 TO TRANSITION AND SUCCESSION AGREEMENT (this Amendment) is made as of this 15th day of October, 2009, by and between Mylan Inc., a Pennsylvania corporation (the Company), and Daniel C. Rizzo, Jr. (Executive).

Transition and Succession Agreement (February 26th, 2010)

This Transition and Succession Agreement (this Agreement) is dated as of February 28_, 2008 (the Commencement Date) by and between Mylan Inc., a Pennsylvania corporation (the Company), and Daniel C. Rizzo, Jr. (the Executive).

Transition and Succession Agreement (August 3rd, 2009)

THIS TRANSITION AND SUCCESSION AGREEMENT (this Agreement) is entered into on June 1, 2009, effective as of June 8, 2009 (the Commencement Date), by and between Mylan Inc., a Pennsylvania corporation (the Company), and Jolene Varney (the Executive).

Amendment No. 1 to Transition and Succession Agreement (February 23rd, 2009)

THIS AMENDMENT TO THE TRANSITION AND SUCCESSION AGREEMENT (this Amendment) by and between Mylan Inc. (the Company) and Rajiv Malik (the Executive), is made as of December 22, 2008.

Amendment No. 3 to Transition and Succession Agreement (February 23rd, 2009)

THIS AMENDMENT TO THE TRANSITION AND SUCCESSION AGREEMENT (this Amendment) by and between Mylan Inc. (the Company) and Edward J. Borkowski (the Executive), is made as of December 22, 2008.

Amendment No. 3 to Transition and Succession Agreement (February 23rd, 2009)

THIS AMENDMENT TO THE TRANSITION AND SUCCESSION AGREEMENT (this Amendment) by and between Mylan Inc. (the Company) and Robert J. Coury (the Executive), is made as of December 22, 2008.

Amendment No. 1 to Transition and Succession Agreement (February 23rd, 2009)

THIS AMENDMENT TO THE TRANSITION AND SUCCESSION AGREEMENT (this Amendment) by and between Mylan Inc. (the Company) and Heather Bresch (the Executive), is made as of December 22, 2008.

Amended and Restated Transition and Succession Agreement (May 12th, 2008)

THIS AMENDED AND RESTATED TRANSITION AND SUCCESSION AGREEMENT (this Agreement) is entered into as of this 31st day of December, 2007 (this Agreement), by and between Mylan Inc., a Pennsylvania corporation (the Company), and Heather Bresch (the Executive).

Transition and Succession Agreement (May 12th, 2008)

THIS TRANSITION AND SUCCESSION AGREEMENT (this Agreement) is entered into as of this 31st day of January, 2007 (this Agreement), by and between Mylan Laboratories Inc., a Pennsylvania corporation (the Company), and Rajiv Malik (the Executive).

Ipc The Hospitalist Company – Succession Agreement (January 14th, 2008)

This Succession Agreement (the Agreement) is made and entered into this day of , 200 , by and among (the Corporation) and ( the Founding Doctor).

Amended and Restated Executive Succession Agreement (November 8th, 2007)

THIS AMENDED AND RESTATED EXECUTIVE SUCCESSION AGREEMENT (this Agreement) is made and entered into by and between Willem P. Roelandts (the Executive), and Xilinx, Inc., a Delaware corporation (the "Company), effective upon the latest date upon which this Agreement is executed below (the "Effective Date"), with reference to the following facts:

Succession Agreement (September 10th, 2007)

This Succession Agreement (this "Agreement") is made and entered into this 31st day of December, 2005 by and among Cartesian Medical Group, Inc. (the "Medical Group"), Bashar Dabbas, M.D., ("Physician") and Genoptix, Inc. d/b/a Genoptix Clinical Laboratory("Genoptix").

Transition and Succession Agreement (May 30th, 2007)

THIS TRANSITION AND SUCCESSION AGREEMENT (this Agreement) is entered into as of this 31st day of January, 2007 (this Agreement), by and between Mylan Laboratories Inc., a Pennsylvania corporation (the Company), and Rajiv Malik (the Executive).

Triad Hospitals – TRUSTEE SUCCESSION AGREEMENT Triad Hospitals, Inc. 7% Senior Subordinated Notes Due 2013 (March 1st, 2007)

This TRUSTEE SUCCESSION AGREEMENT effective as of October 9, 2006 (Agreement), is among Triad Hospitals, Inc. (the Company), Citibank, N.A. (Prior Trustee), and The Bank of New York, Trust Company N.A. (the Successor Trustee).

Triad Hospitals – TRUSTEE SUCCESSION AGREEMENT Triad Hospitals, Inc. Senior Debt Securities (March 1st, 2007)

This TRUSTEE SUCCESSION AGREEMENT effective as of October 9, 2006 (Agreement), is among Triad Hospitals, Inc. (the Company), Citibank, N.A. (Prior Trustee), and The Bank of New York, Trust Company N.A. (the Successor Trustee).

Transition and Succession Agreement (January 10th, 2007)

THIS TRANSITION AND SUCCESSION AGREEMENT (this Agreement) is entered into as of this 8th day of January, 2007 (this Agreement), by and between Mylan Laboratories Inc., a Pennsylvania corporation (the Company), and Prasad Nimmagadda (the Executive).

Employment Succession Agreement (August 7th, 2006)

This Employment Succession Agreement (the Agreement) is made and entered into effective as of June 1, 2006 (the Effective Date), by and between Amylin Pharmaceuticals, Inc., a Delaware corporation (the Company), and Daniel M. Bradbury (the Executive). The Company and the Executive are hereinafter collectively referred to as the Parties and individually referred to as a Party.

Amendment No. 1 to Transition and Succession Agreement (May 16th, 2006)

THIS AMENDMENT NO. 1 TO TRANSITION AND SUCCESSION AGREEMENT (this Amendment) by and between Mylan Laboratories Inc., a Pennsylvania corporation (the Company), and (the Executive), is made as of March 31, 2006.

Amendment No. 2 to Transition and Succession Agreement (May 16th, 2006)

THIS AMENDMENT NO. 2 TO TRANSITION AND SUCCESSION AGREEMENT (this Amendment) by and between Mylan Laboratories Inc., a Pennsylvania corporation (the Company) and Robert J. Coury (the Executive), is made as of April 3, 2006.